Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography

Recent acquisition of DART™ (Direct Analysis Real-time Technology) innovator IonSense extends Bruker’s unique Point-of-Need (PoN) mass spectrometers Launch of DART-EVOQ® triple quadrupole mass spectrometer offers simple, robust, yet sensitive and specific PoN workflows for applied markets New Bruker strategic partnership with TOFWERK AG brings together skills and vision for next-generation high-speed, ultra-sensitive analytical solutions MINNEAPOLIS–(BUSINESS … [Read more…]

S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples

Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples LIVERMORE, Calif.–(BUSINESS WIRE)–#AGBT2022–S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample … [Read more…]

NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

A cloud-based, integrated informatics ecosystem for spatial biology with advanced analytics enabling data sharing and collaboration SEATTLE–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial Informatics Portal (SIP) at the Spatial Multiomic Symposium at the 2022 … [Read more…]

United Therapeutics Provides an Update on Its Organ Printing Programs

Lung scaffolds developed in partnership with 3D Systems Corporation represent the most complex objects ever printed; reveal took place at the LIFE ITSELF Conference in San Diego 3D-printed lung scaffolds are demonstrating gas exchange in animal models United Therapeutics expects human clinical trials of 3D-printed, cellularized lungs in the next five years SILVER SPRING, Md. … [Read more…]

Global Gastroenterology Ambulatory Surgery Center Market Research Report to 2027 – Featuring Boston Scientific, Cardinal Health, Community Health Systems and CONMED Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastroenterology Ambulatory Surgery Center Market Research Report by Services (Diagnostic Services and Surgical Services), Ownership, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Gastroenterology Ambulatory Surgery Center Market size was estimated at USD … [Read more…]

Insights on the Orthopedic Soft Tissue Repair Global Market to 2027 – Ongoing Technology Innovations and Therapies Such as Platelet-rich Plasma Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Soft Tissue Repair Market Research Report by Procedure, Injury Location, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Orthopedic Soft Tissue Repair Market size was estimated at USD 4,546.87 million in 2021, USD 5,444.34 million in 2022, and is projected … [Read more…]

Chlorella Industry Has Acquired FDA GRAS Certification for the Chlorella Powder Product, Unprecedented in Japan for the Exclusively Domestic Cultivation and Production of Chlorella

TOKYO–(BUSINESS WIRE)–Chlorella Industry Co., Ltd. (Minato-ku, Tokyo) has acquired FDA GRAS (Generally Recognized As Safe) certification for the chlorella powder product, unprecedented in Japan for the exclusively domestic cultivation and production of chlorella. Chlorella is a plant-based food source, made up of about 60% protein, and comprised of a variety of vitamins and minerals, chlorophyll … [Read more…]

LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing

Series B co-led by Fast Track Initiative, DCI Partners, and 4BIO Capital Proceeds to accelerate development of LUCA’s novel Mitochondria Isolation Technology (MIT) platform, IND-enabling activities for its in-house pipeline and establish its manufacturing capability TOKYO–(BUSINESS WIRE)–LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutical agents, today announced the … [Read more…]

Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022

STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that it presented updated preliminary Phase I data on TG4050, its individualized neoantigen cancer vaccine, in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting. TG4050 … [Read more…]

Global Mercy™ Begins Local Healthcare Training, Following Historic Week of Events in Dakar

A prestigious award for founder Don Stephens and blessing of the Global Mercy™ add to the launch of a packed training schedule designed to increase healthcare capacity in Africa DAKAR, Senegal–(BUSINESS WIRE)–In the midst of celebrations around the arrival of the Global Mercy™ to Senegal, training has already begun by the crew of the world’s … [Read more…]